Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

351 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy of rituximab in systemic manifestations of primary Sjogren's syndrome: results in 78 patients of the AutoImmune and Rituximab registry.
Gottenberg JE, Cinquetti G, Larroche C, Combe B, Hachulla E, Meyer O, Pertuiset E, Kaplanski G, Chiche L, Berthelot JM, Gombert B, Goupille P, Marcelli C, Feuillet S, Leone J, Sibilia J, Zarnitsky C, Carli P, Rist S, Gaudin P, Salliot C, Piperno M, Deplas A, Breban M, Lequerre T, Richette P, Ghiringhelli C, Hamidou M, Ravaud P, Mariette X; Club Rhumatismes et Inflammations and the French Society of Rheumatology. Gottenberg JE, et al. Among authors: berthelot jm. Ann Rheum Dis. 2013 Jun;72(6):1026-31. doi: 10.1136/annrheumdis-2012-202293. Epub 2012 Dec 21. Ann Rheum Dis. 2013. PMID: 23264337
Clinical practice decision tree for the choice of the first disease modifying antirheumatic drug for very early rheumatoid arthritis: a 2004 proposal of the French Society of Rheumatology.
Le Loët X, Berthelot JM, Cantagrel A, Combe B, De Bandt M, Fautrel B, Flipo RM, Lioté F, Maillefert JF, Meyer O, Saraux A, Wendling D, Guillemin F. Le Loët X, et al. Among authors: berthelot jm. Ann Rheum Dis. 2006 Jan;65(1):45-50. doi: 10.1136/ard.2005.035436. Epub 2005 Jun 30. Ann Rheum Dis. 2006. PMID: 15994280 Free PMC article.
Clinical practice format for choosing a second-line disease modifying anti-rheumatic drug in early rheumatoid arthritis after failure of 6 months' first-line DMARD therapy.
Meyer O, de Bandt M, Berthelot JM, Cantagrel A, Combe B, Fautrel B, Flipo RM, Lioté F, Maillefert JF, Saraux A, Wendling D, Guillemin F, Le Loët X; Working Group for Therapeutic Strategies for Rheumatoid Arthritis. Meyer O, et al. Among authors: berthelot jm. Joint Bone Spine. 2007 Jan;74(1):73-8. doi: 10.1016/j.jbspin.2006.05.008. Epub 2006 Nov 29. Joint Bone Spine. 2007. PMID: 17194614
Characteristics and survival of 26 patients with paraneoplastic arthritis.
Morel J, Deschamps V, Toussirot E, Pertuiset E, Sordet C, Kieffer P, Berthelot JM, Champagne H, Mariette X, Combe B. Morel J, et al. Among authors: berthelot jm. Ann Rheum Dis. 2008 Feb;67(2):244-7. doi: 10.1136/ard.2007.070086. Epub 2007 Jun 29. Ann Rheum Dis. 2008. PMID: 17604284
Choice of second-line disease-modifying antirheumatic drugs after failure of methotrexate therapy for rheumatoid arthritis: a decision tree for clinical practice based on rheumatologists' preferences.
Fautrel B, Guillemin F, Meyer O, de Bandt M, Berthelot JM, Flipo RM, Lioté F, Maillefert JF, Wendling D, Saraux A, Combe B, Le Loët X; Stratégies Thérapeutiques dans La Polyarthrite RhumatoIde Working Group; Club Rhumatismes et Inflammation; French Society of Rheumatology. Fautrel B, et al. Among authors: berthelot jm. Arthritis Rheum. 2009 Apr 15;61(4):425-34. doi: 10.1002/art.24588. Arthritis Rheum. 2009. PMID: 19333993 Free article.
351 results